Bullboard - Stock Discussion Forum Corbus Pharmaceuticals Holdings Inc CRBP

Healthcare Biotechnology

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks... see more

Add To Watchlist

NDAQ:CRBP - Post Discussion

Corbus Pharmaceuticals Holdings Inc > Corbus Pharmaceuticals to Present at the Oppenheimer 34th An

View:

Post by whytestocks on Feb 06, 2024 8:30pm

Corbus Pharmaceuticals to Present at the Oppenheimer 34th An

News; $CRBP Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNORWOOD, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one...CRBP - Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference